The Result of Timely Therapy for Whipple's Disease: a Clinical Case

The Result of Timely Therapy for Whipple's Disease: a Clinical Case

Аim: to provide basic information on Whipple's disease necessary for timely diagnosis and treatment, using the example of clinical observation.Key points. Whipple's disease is a rare systemic infectious disease that internists, gastroenterologists, rheumatologists, and other physicians may...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. N. Mekhtiev, O. A. Mekhtieva, E. Yu. Kalinina, V. E. Karev, A. V. Vanyan, O. M. Berko
Format:	Article
Language:	Russian
Published:	Gastro LLC 2024-01-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	whipple's disease tropheryma whipplei malabsorption trimethoprim/sulfamethoxazole
Online Access:	https://www.gastro-j.ru/jour/article/view/841
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Whipple's Disease in a 61-Year-Old Patient. Clinical Follow-Up
by: Zh. G. Simonova, et al.
Published: (2024-05-01)

A Case of Medullary Carcinoma of the Jejunum Combined with the Intestinal Lymphangiectasia Accompanied by the Malabsorption Syndrome
by: O. A. Lobanova, et al.
Published: (2023-11-01)

SYNTHESIS AND CHARACTERIZATION OF NEW POLYMERIC COATINGS FROM ANTHOCYANIN DYE AND STUDY BIOLOGICAL ACTIVITY
by: Mayson Thafir Hadi, et al.
Published: (2025-01-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

Gene therapy by hepatocyte growth factor results in regression of experimental liver fibrosis
by: N. A. Dzhoyashvili, et al.
Published: (2010-08-01)

Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy
by: S. N. Mekhdiyev, et al.
Published: (2022-12-01)

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Dynamics of Somatic and Comorbid Mental Disorders (Distress, Anxiety, Somatisation and Depression) in Patients with Irritable Bowel Syndrome during Therapy with Alimemazine: Results of an Non-Interventional Observational Programme (“Terra”)
by: V. T. Ivashkin, et al.
Published: (2019-01-01)

Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response
by: T. M. Ignatova, et al.
Published: (2013-09-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Antioxidants and Cognitive-Behavioral Therapy in Patients with Functional Dyspepsia
by: T. V. Sapozhnikova, et al.
Published: (2023-09-01)

Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study
by: A. O. Bueverov, et al.
Published: (2024-03-01)

Results of formation of primary and secondary smallintestinal reservoirs at ulcerative colitis
by: V. N. Kashnikov, et al.
Published: (2014-12-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

Results of multicenter observation study on application of international questionnaire GerdQ for diagnostics of gastroesophageal reflux disease
by: V. O. Kaybysheva, et al.
Published: (2013-10-01)

Results of endoscopic treatment of early colorectal cancer
by: M. Yu. Agapov, et al.
Published: (2011-06-01)

Efficacy of the herbal preparation STW 5 in multi-target therapy of functional dyspepsia
by: A. A. Sheptulin, et al.
Published: (2015-10-01)

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
by: P. O. Bogomolov, et al.
Published: (2024-12-01)

The resolution of Advisory council «How to improve treatment results functional dyspepsia and irritable bowel syndrome»?
by: V. T. Ivashkin, et al.
Published: (2016-08-01)

Efficacy of drugs most commonly prescribed at functional gastrointestinal diseases (functional dyspepsia syndrome and irritable bowel syndrome) observational study results
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Antibiotic-resistance of H. pylori: results of microbiologic regional investigation
by: N. N. Dekhnich, et al.
Published: (2011-03-01)

Results of the ORION open comparative randomized trial: evaluation of efficacy of the Russian drugs Altevir and Phosphogliv in combined treatment of chronic hepatitis C
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice
by: O. S. Shifrin, et al.
Published: (2020-04-01)

Results of long-term follow-up of patients with chronic gastritis after <i>H. pylori</i> eradication
by: T. L. Lapina, et al.
Published: (2015-09-01)

Results of Selective Biochemical Screening for Lysosomal Acid Lipase Deficiency and Sequencing of the <i>LIPA</i> Gene in the Risk Group Patients
by: S. V. Shtykalova, et al.
Published: (2025-02-01)

Hymecromone Administration in Real Clinical Practice: Results of the Prospective Multicentre Observational Study in the Republic of Kazakhstan
by: A. V. Nersesov, et al.
Published: (2022-01-01)

Whether pH-metry and investigation of esophageal motor function are necessary for diagnosis and choice of therapy for us today?
by: O. A. Storonova, et al.
Published: (2010-04-01)

Chronic inflammatory bowel diseases: the course and treatment methods in Russian Federation (Results of multicenter population-based one-stage observational study)
by: L. . Khalif, et al.
Published: (2018-08-01)

Requiring durations of therapy at the time of antibiotic order entry reduces antibiotic use
by: Megan R. Wright, et al.
Published: (2025-01-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Effect of combined therapy by pinaverium bromide and itopride hydrochloride on clinical semiology and quality of life of patients with combination of constipation variant of irritable bowel syndrome and functional dyspepsia
by: O. V. Krapivnaya, et al.
Published: (2015-05-01)

PRELIMINARY RESULTS OF GEO-ARCHAEOLOGICAL RESEARCH OBTAINED DURING THE 3rd INTERNATIONAL EXPEDITION OF THE R/V “MARE NIGRUM” (01.06.2024 – 15.06.2024)
by: M.M. Ievlev, et al.
Published: (2024-10-01)

Basic Molecular Biology, Metabolic and Immunological Mechanisms of Fecal Microbiota Transplantation
by: O. V. Goloshchapov, et al.
Published: (2024-12-01)

Short-term results of treatment of non-epithelial gastro-intestinal tumors complicated by bleeding
by: S. G. Shapovalyants, et al.
Published: (2011-09-01)

Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
by: O. V. Krapivnaya
Published: (2014-07-01)

The effect of maintenance therapy on Crohn’s disease clinical outcomes
by: O. B. Schukina, et al.
Published: (2018-08-01)

On the reduction of imaging time-points for dosimetry in radionuclide therapy
by: Johan Gustafsson, et al.
Published: (2025-02-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)